LY2109761

Cat. No.: OB0225LY-0198

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR and HPLC.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: LY2109761 is a small molecule inhibitor of the TGF-β signaling pathway, which interferes with TGF-β-mediated cell proliferation and migration.

Synonym: 700874-71-1; LY-2109761; LY 2109761; 4-(2-((4-(2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl)oxy)ethyl)morpholine; 4-[2-[4-(2-Pyridin-2-yl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl]oxyethyl]morpholine; 4-[5,6-Dihydro-2-(2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-7-[2-(4-morpholinyl)ethoxy]quinoline; 4-(5,6-Dihydro-2-(2-pyridinyl)-4H-pyrrolo(1,2-b)pyrazol-3-yl)-7-(2-(4-morpholinyl)ethoxy)quinoline; 4-[5,6-dihydro-2-(2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-7-[2-(4-morpholinyl)ethoxy]-quinoline

CAS No.: 700874-71-1

Compound CID: 11655119

Formula: C₂₆H₂₇N₅O₂

Formula Weight: 441.52

Specification

Relative Density: 1.34 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: LY2109761 can be used in tumor biology or fibrosis research, or play an important role in studying the role of TGF-β signaling in disease.